Drug sensitivity ("suicide") genes for selective cancer chemotherapy

Cancer Gene Ther. 1994 Dec;1(4):279-87.
No abstract available

Publication types

  • Review

MeSH terms

  • Acyclovir / pharmacokinetics
  • Acyclovir / therapeutic use
  • Animals
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Biotransformation / genetics*
  • Cytosine Deaminase
  • Drug Resistance / genetics*
  • Escherichia coli Proteins
  • Ganciclovir / pharmacokinetics
  • Ganciclovir / therapeutic use
  • Gene Expression Regulation
  • Genetic Therapy / methods*
  • Genetic Vectors / genetics
  • Humans
  • Mice
  • Mice, Transgenic
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / prevention & control
  • Nucleoside Deaminases / genetics
  • Nucleoside Deaminases / metabolism
  • Pentosyltransferases
  • Precancerous Conditions / therapy
  • Prodrugs / pharmacokinetics*
  • Promoter Regions, Genetic
  • Proteins*
  • Purine-Nucleoside Phosphorylase / genetics
  • Purine-Nucleoside Phosphorylase / metabolism
  • Rats
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Recombinant Fusion Proteins / therapeutic use*
  • Thymidine Kinase / genetics
  • Thymidine Kinase / metabolism
  • Viral Proteins / genetics
  • Viral Proteins / metabolism
  • alpha-Fetoproteins / genetics

Substances

  • Bacterial Proteins
  • Escherichia coli Proteins
  • Prodrugs
  • Proteins
  • Recombinant Fusion Proteins
  • Viral Proteins
  • alpha-Fetoproteins
  • Pentosyltransferases
  • Purine-Nucleoside Phosphorylase
  • Gpt protein, E coli
  • Thymidine Kinase
  • Nucleoside Deaminases
  • Cytosine Deaminase
  • Ganciclovir
  • Acyclovir